sargramostim
pharmaceutical drug
Facts
8 properties- Instance of
- type of chemical entity
- Subclass of
- leukocyte growth factor, granulocyte-macrophage colony-stimulating factor, recombinant protein[2][3][4]
- Has use
- medication[5]
- Defined daily dose
- 0.45 mg[14]
- Different from
- Colony stimulating factor 2[7]
- Has characteristic
- biopharmaceutical[6]
- Medical condition treated
- lymphosarcoma, lymphoid leukemia, Hodgkin's lymphoma, mixed cellularity, breast cancer, melanoma[8][9][10][11][12]
- Subject has role
- immunologic factor[13]
🏷️ Also known as
en sargramostim
en B1 61.012
en Leukine
en recombinant GM-CSF
ar سارغراموستيم
ja サルグラモスチム
uk сарграмостим
zh 沙格司亭
🔖 Identifiers · 15
- ATC code
- L03AA09
- ChEMBL ID
- CHEMBL1201670
- DrugBank ID
- DB00020
- Encyclopædia Britannica Online ID
- science/sargramostim
- Freebase ID
- /m/02wvcjd
- Guide to Pharmacology Ligand ID
- 7905
- MeSH descriptor ID
- C081222
- MedlinePlus drug identifier
- a693005
- Microsoft Academic ID (discontinued)
- 2776186052
- NCI Drug Dictionary ID
- sargramostim
- NDF-RT ID
- N0000147658
- PatientsLikeMe treatment ID
- 1889, sargramostim
Show all 15 identifiers +3
- RxNorm CUI
- 69634
- UNII
- 5TAA004E22
- WikiProjectMed ID
- Sargramostim
🔗 Connections
← Drug or therapy used for treatment 3
Medical condition treated 2
Different from 1
Has characteristic 1
Has use 1
← Different from 1
Press Enter · cited answer in seconds
0 sources
Summary
sargramostim is a type of chemical entity[1].